Mitochondrial dysfunction is recognized as being an important mechanism through which Parkinson’s disease (PD) can arise. In particular, decrease of mitochondrial complex 1 (MCI) activity in dopaminergic neurons of the substantia nigra (SN) has been observed in PD; however, its role in the pathogenesis of PD remains unclear.1, 2 Mitochondrial protection or rescue therapies are potential approaches through which disease modification of PD may be achieved in the future.
Training and Networking Working Group
The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group 
